4
Changes in Ownership
RECURSION PHARMACEUTICALS, INC. Filed Acc 0001601830-24-000176
Chief Financial Officer sold 30,000 shares at an average $6.34 ($190,131)
- Chief Financial Officer acquired 78,750 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Secora Michael · Chief Financial Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-10-08 | Exercise or conversion : show line 1 in the form 10b5-1 | +39,375 | $2.22 | $87,413 | 1,441,506 | D |
| 2024-10-08 | Sale : show line 2 in the form 10b5-1 | −15,000 | $6.32 | $94,757 | 1,426,506 | D |
| 2024-10-09 | Exercise or conversion : show line 3 in the form 10b5-1 | +39,375 | $2.22 | $87,413 | 1,465,881 | D |
| 2024-10-09 | Sale : show line 4 in the form 10b5-1 | −15,000 | $6.36 | $95,375 | 1,450,881 | D |
| Open-market sales · 30,000 sh · avg $6.34 · $190,131 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-10-08 | Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (Right to Buy) | −39,375 | 455,760 | D |
| 2024-10-09 | Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) | −39,375 | 416,385 | D |
Loading xslF345X05/wk-form4_1728600038.xml…